Werfen Hospital Group

Werfen is a global leader in specialized in vitro diagnostics (IVD), focusing on Hemostasis, Acute Care Diagnostics, Autoimmunity, Transfusion, and Transplant. Founded in 1966 and headquartered in Barcelona, Spain, the company develops, manufactures, and distributes high-quality instruments, reagents, and data management solutions for hospitals and clinical laboratories worldwide. Key product lines include the ACL TOP family for hemostasis and the GEM Premier systems for acute care, which are essential for managing critical patients in intensive care and emergency settings. Werfen has expanded its global footprint through strategic acquisitions, including Instrumentation Laboratory, Inova Diagnostics, Biokit, and more recently, Immucor and Omixon. The company operates directly in 30 countries and serves more than 100 territories through an extensive distribution network.